Contribute Try STAT+ Today

Hello, everyone, and how are you today? Cold winds are whipping about the Pharmalot campus, where things have settled down now that the short person is hovering over the laptop once again and the official mascot has assumed his formal snoozing position. As for us, we are dutifully concocting a few needed cups of stimulation as we dig in for another busy day. No doubt, you can relate. So time to get cracking. As always, we have assembled some items of interest. So hoist your own cup to a successful day, and drop us a line when something interesting arises. …

At least one Democratic lawmaker is openly pushing President Biden to include drug pricing reform in his next big legislative package, after rumors swirled on Capitol Hill that the forthcoming bill might not include such provisions, STAT reports. Rep. Peter Welch of Vermont planned to call the White House and is urging his colleagues to pressure the administration in a letter, too. His efforts suggest drug pricing advocates could face an uphill battle passing major drug pricing reform, even though Democrats control the House, Senate, and White House.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.